Vaneck Vectors Global Health Leaders ETF (ASX:HLTH)
Australia · Delayed Price · Currency is AUD 11.64
+0.06 (0.52%)
At close: Jul 28, 2026
ASX:HLTH Holdings Information
ASX:HLTH is an equity ETF with a total of 10 individual holdings. The top holdings are Illumina stock at 3.23%, Arrowhead Pharmaceuticals at 3.08%, West Pharmaceutical Services at 2.95%, Exelixis at 2.64%, and Neurocrine Biosciences at 2.62%.
Total Holdings
10
Top 10 Percentage
27.13%
Asset Class
Equity
ETF Category
Health Care
Assets
50.55M
PE Ratio
20.73
Breakdown by Country
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | ILMN | Illumina, Inc. | 3.23% |
| 2 | ARWR | Arrowhead Pharmaceuticals, Inc. | 3.08% |
| 3 | WST | West Pharmaceutical Services, Inc. | 2.95% |
| 4 | EXEL | Exelixis, Inc. | 2.64% |
| 5 | NBIX | Neurocrine Biosciences, Inc. | 2.62% |
| 6 | SWX: YPSN | Ypsomed Holding AG | 2.58% |
| 7 | ARGX | argenx SE | 2.58% |
| 8 | CPH: NOVO.B | Novo Nordisk A/S | 2.51% |
| 9 | HALO | Halozyme Therapeutics, Inc. | 2.48% |
| 10 | INCY | Incyte Corporation | 2.46% |
As of Jul 23, 2026